ArticlePloS one2019

Urate-lowering agents for asymptomatic hyperuricemia in stage 3 - 4 chronic kidney disease: Controversial role of kidney function.

Hee Jung Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.